Elisabeth Bertrand

967 total citations
18 papers, 645 citations indexed

About

Elisabeth Bertrand is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Elisabeth Bertrand has authored 18 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Immunology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Elisabeth Bertrand's work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (8 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Elisabeth Bertrand is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (8 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Elisabeth Bertrand collaborates with scholars based in France, United Kingdom and Australia. Elisabeth Bertrand's co-authors include Bruno Quesnel, Xavier Leleu, Charles Herbaux, Stéphanie Poulain, Claude Preudhomme, Christophe Roumier, Aline Renneville, Sabine Tricot, Patrick Duthilleul and Olivier Nibourel and has published in prestigious journals such as The EMBO Journal, Blood and The Journal of Immunology.

In The Last Decade

Elisabeth Bertrand

18 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Bertrand France 9 347 309 294 216 110 18 645
Kamlai Saiya-Cork United States 11 201 0.6× 222 0.7× 131 0.4× 191 0.9× 53 0.5× 15 480
Michela Frenquelli Italy 13 300 0.9× 173 0.6× 260 0.9× 367 1.7× 107 1.0× 19 720
Bertrand Montpellier France 6 103 0.3× 144 0.5× 163 0.6× 209 1.0× 116 1.1× 9 506
María Hernández‐Sánchez Spain 14 232 0.7× 149 0.5× 138 0.5× 196 0.9× 66 0.6× 42 451
Rebecca Auer United Kingdom 14 445 1.3× 469 1.5× 100 0.3× 143 0.7× 98 0.9× 36 647
Panagiotis Baliakas Sweden 11 312 0.9× 224 0.7× 156 0.5× 113 0.5× 95 0.9× 34 443
Gianluca Schiavoni Italy 10 276 0.8× 177 0.6× 128 0.4× 184 0.9× 46 0.4× 17 440
Brenda Verhaaf Netherlands 10 134 0.4× 147 0.5× 161 0.5× 168 0.8× 83 0.8× 12 460
Elena Ruíz-Ballesteros Spain 8 211 0.6× 299 1.0× 96 0.3× 174 0.8× 25 0.2× 8 468
Davide Bagnara Italy 12 253 0.7× 164 0.5× 345 1.2× 106 0.5× 46 0.4× 29 511

Countries citing papers authored by Elisabeth Bertrand

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Bertrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Bertrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Bertrand more than expected).

Fields of papers citing papers by Elisabeth Bertrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Bertrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Bertrand. The network helps show where Elisabeth Bertrand may publish in the future.

Co-authorship network of co-authors of Elisabeth Bertrand

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Bertrand. A scholar is included among the top collaborators of Elisabeth Bertrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Bertrand. Elisabeth Bertrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Poulain, Stéphanie, Christophe Roumier, Elisabeth Bertrand, et al.. (2017). TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia. Clinical Cancer Research. 23(20). 6325–6335. 62 indexed citations
2.
Bertrand, Elisabeth, Nathalie Jouy, Salomon Manier, et al.. (2017). Role of IRF4 in resistance to immunomodulatory (IMid) compounds® in Waldenström’s macroglobulinemia. Oncotarget. 8(68). 112917–112927. 5 indexed citations
3.
Bevington, Sarah L., Pierre Cauchy, Jason Piper, et al.. (2016). Inducible chromatin priming is associated with the establishment of immunological memory in T cells. The EMBO Journal. 35(5). 515–535. 81 indexed citations
4.
Herbaux, Charles, Elisabeth Bertrand, Guillemette Marot, et al.. (2016). BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia. Oncotarget. 8(34). 57451–57459. 1 indexed citations
5.
Poulain, Stéphanie, Christophe Roumier, Elisabeth Bertrand, et al.. (2016). TP53 Mutation in Waldenstrom Macroglobulinemia. Blood. 128(22). 4092–4092. 1 indexed citations
6.
Poulain, Stéphanie, Christophe Roumier, Martin Figeac, et al.. (2015). Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia. Clinical Cancer Research. 22(6). 1480–1488. 82 indexed citations
7.
Hétuin, Dominique, Céline Berthon, Anne Loyens, et al.. (2014). RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage. Cell Death and Disease. 5(8). e1384–e1384. 107 indexed citations
8.
Poulain, Stéphanie, Eileen M. Boyle, Christophe Roumier, et al.. (2014). MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome. British Journal of Haematology. 167(4). 506–513. 48 indexed citations
9.
Fostier, Karel, Sandrine Aspeslagh, Wim Renmans, et al.. (2013). Preclinical Evaluation of Invariant Natural Killer T Cells in the 5T33 Multiple Myeloma Model. PLoS ONE. 8(5). e65075–e65075. 25 indexed citations
10.
Poulain, Stéphanie, Charles Herbaux, Elisabeth Bertrand, et al.. (2013). Genomic Studies Have Identified Multiple Mechanisms of Genetic Changes in Waldenström Macroglobulinemia. Clinical Lymphoma Myeloma & Leukemia. 13(2). 202–204. 6 indexed citations
11.
Poulain, Stéphanie, Christophe Roumier, Aline Renneville, et al.. (2013). MYD88 L265P mutation in Waldenstrom macroglobulinemia. Blood. 121(22). 4504–4511. 161 indexed citations
12.
Poulain, Stéphanie, Christophe Roumier, Sylvie Galiègue‐Zouitina, et al.. (2013). Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia. American Journal of Hematology. 88(11). 948–954. 29 indexed citations
13.
Baxter, Euan W., Fabio Mirabella, Sarion R. Bowers, et al.. (2012). The Inducible Tissue-Specific Expression of the Human IL-3/GM-CSF Locus Is Controlled by a Complex Array of Developmentally Regulated Enhancers. The Journal of Immunology. 189(9). 4459–4469. 8 indexed citations
14.
Poulain, Stéphanie, Christophe Roumier, Aline Renneville, et al.. (2012). MYD88 L265P Mutation in Waldenstrom's Macroglogulinemia. Blood. 120(21). 1307–1307. 2 indexed citations
15.
Poulain, Stéphanie, Christophe Roumier, Charles Herbaux, et al.. (2012). Genome Wide SNP Array (SNPa) Analysis Reveals Clonal Evolution During Clinical Course in Waldenstrom's Macroglobulinemia (WM). Blood. 120(21). 297–297. 2 indexed citations
16.
Muller, Sylviane, Elisabeth Bertrand, Monique Érard, & M.H.V. Van Regenmortel. (1985). pH-induced conformational changes in chromatin subunits measured by circular dichroism and immunochemical reactivity. International Journal of Biological Macromolecules. 7(2). 113–119. 7 indexed citations
17.
Bertrand, Elisabeth, Monique Érard, Macarena Gomez‐Lira, & Jürgen Bode. (1984). Influence of histone hyperacetylation on nucleosomal particles as visualized by electron microscopy. Archives of Biochemistry and Biophysics. 229(1). 395–398. 13 indexed citations
18.
Bertrand, Elisabeth, et al.. (1969). French Music in the Fifteenth and Sixteenth Centuries. Renaissance and Reformation. 14(1). 88–91. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026